TNFA

TNF Pharmaceuticals, Inc. Common Stock

3 hedge funds and large institutions have $2.8M invested in TNF Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$1M
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$622K +$622K +1 New
BlackRock
3
BlackRock
New York
$509K +$509K +1 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$177K -$260K
Citadel Advisors
5
Citadel Advisors
Florida
$115K -$267K
VF
6
Virtu Financial
New York
$103K
Northern Trust
7
Northern Trust
Illinois
$60K -$128K
BA
8
Bard Associates
Illinois
$45K -$101K
IA
9
IFP Advisors
Florida
$43K -$11K
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$25K -$54K
IG
11
ING Group
Netherlands
$22K
RE
12
RBC Europe
United Kingdom
$15.1K -$32.3K
State Street
13
State Street
Massachusetts
$11K -$24K
AG
14
Advisor Group
Arizona
$11K -$24K
HSBC Holdings
15
HSBC Holdings
United Kingdom
$10K -$22K
Jane Street
16
Jane Street
New York
$10K -$29K
Invesco
17
Invesco
Georgia
$9K
UBS Group
18
UBS Group
Switzerland
$4K
JPMPWA
19
J.P. Morgan Private Wealth Advisors
California
$4K -$8K
RCAG
20
Rehmann Capital Advisory Group
Michigan
$2.71K
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
-$42K
SFSIG
22
San Francisco Sentry Investment Group
California
-$8K
CCM
23
Courage Capital Management
Tennessee
-$299K